Bevacizumab for recurrent malignant gliomas : Efficacy, toxicity, and patterns of recurrence von NORDEN, A. D, YOUNG, G. S, KESARI, S, WEN, P. Y, SETAYESH, K, MUZIKANSKY, A, KLUFAS, R, ROSS, G. L, CIAMPA, A. S, EBBELING, L. G, LEVY, B, DRAPPATZ, J

Volltext

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice von Sequist, L.V., Heist, R.S., Shaw, A.T., Fidias, P., Rosovsky, R., Temel, J.S., Lennes, I.T., Digumarthy, S., Waltman, B.A., Bast, E., Tammireddy, S., Morrissey, L., Muzikansky, A., Goldberg, S.B., Gainor, J., Channick, C.L., Wain, J.C., Gaissert, H., Donahue, D.M., Muniappan, A., Wright, C., Willers, H., Mathisen, D.J., Choi, N.C., Baselga, J., Lynch, T.J., Ellisen, L.W., Mino-Kenudson, M., Lanuti, M., Borger, D.R., Iafrate, A.J., Engelman, J.A., Dias-Santagata, D.

Volltext

Real world cfDNA collection in EGFR-mutant NSCLC von Marcoux, N., Sequist, L.V., Hata, A., Banwait, M., Dagogo-Jack, I., Nagy, R., Lanman, R.B., Muzikansky, A., Digumarthy, S.R., Piotrowska, Z.

Volltext

Patient-Level Factors Associated with Oncology Provider-Delivered Brief Tobacco Treatment Among Recently Diagnosed Cancer Patients von Neil, JM, Price, SN, Friedman, ER, Ponzani, C, Ostroff, JS, Muzikansky, A, Park, ER

Volltext

Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study von Lin, J.J., Muzikansky, A., Kennedy, E., Kuberski, H., Stober, L.L., Wanat, A.C., Azzoli, C.G., Lennes, I., Sequist, L.V., Dagogo-Jack, I., Shaw, A.T., Gainor, J.F.

Volltext

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer von Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Earle, C. C., Kulke, M. H., Meyerhardt, J. A., Blaszkowsky, L. S., Zhu, A. X., Fidias, P., Vincitore, M. M., Mayer, R. J., Fuchs, C. S.

Volltext

KRAS Mutation is Associated with Decreased Overall Survival after Thoracic Radiation Therapy in Patients with Locally Advanced Non-small Cell Lung Cancer von Mak, R.H, Doran, E, Muzikansky, A, Neal, J.W, Baldini, E.H, Choi, N.C, Willers, H, Jackman, D.M, Sequist, L.V

Volltext

A Phase II Study of Epirubicin and Thalidomide in Unresectable or Metastatic Hepatocellular Carcinoma von Zhu, Andrew X., Fuchs, Charles S., Clark, Jeffrey W., Muzikansky, Alona, Taylor, Kerry, Sheehan, Susan, Tam, Kayao, Yung, Elizabeth, Kulke, Matthew H., Ryan, David P.

Volltext

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma von ZHU, Andrew X, BLASZKOWSKY, Lawrence S, STUART, Keith, RYAN, David P, CLARK, Jeffrey W, MUZIKANSKY, Alona, HORGAN, Kerry, SHEEHAN, Susan, HALE, Kelly E, ENZINGER, Peter C, BHARGAVA, Pankaj

Volltext

Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients von Hasserjian, R P, Goodman, H J B, Lachmann, H J, Muzikansky, A, Hawkins, P N

Volltext

The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas von CHAKRAVARTI, Arnab, ZHAI, Gary, SUZUKI, Yoshiyuki, SARKESH, Sormeh, BLACK, Peter M, MUZIKANSKY, Alona, LOEFFLER, Jay S

Volltext

Computed Tomography Imaging Characteristics of Non–Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis von Mendoza, Dexter P., Stowell, Justin, Muzikansky, Alona, Shepard, Jo-Anne O., Shaw, Alice T., Digumarthy, Subba R.

Volltext

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes von Dadras, Soheil S, Lange-Asschenfeldt, Bernhard, Velasco, Paula, Nguyen, Lynh, Vora, Anish, Muzikansky, Alona, Jahnke, Katharina, Hauschild, Axel, Hirakawa, Satoshi, Mihm, Martin C, Detmar, Michael

Volltext

490P - Response rates and lesion-level progression patterns of solid tumor patients in an academic phase I program: implications for tumour heterogeneity von Chen, C., Pinto, C., Walmsley, C., Allen, R., Muzikansky, A., Henderson, L., Broudo, M., Wolfgang, J., Fitzgerald, D.M., Hong, T., Juric, D.

Volltext

Response rates and lesion-level progression patterns of solid tumor patients in an academic phase I program: implications for tumour heterogeneity von Chen, C., Pinto, C., Walmsley, C., Allen, R., Muzikansky, A., Henderson, L., Broudo, M., Wolfgang, J., Fitzgerald, D.M., Hong, T., Juric, D.

Volltext

Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease von BELLOVIN, David I, BATES, Richard C, MUZIKANSKY, Alona, RIMM, David L, MERCURIO, Arthur M

Volltext

PS02.26 Multifocal Adenocarcinoma of the Lung: Factors Predictive for Local Therapy von Mooradian, M.J., Price, M., Muzikansky, A., Lennes, I., Lanuti, M., Willers, H., Digumarthy, S., Sequist, L.V.

Volltext

1346PReal world cfDNA collection in EGFR-mutant NSCLC von Marcoux, N, Sequist, L V, Hata, A, Banwait, M, Dagogo-Jack, I, Nagy, R, Lanman, R B, Muzikansky, A, Digumarthy, S R, Piotrowska, Z

Volltext

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma von Norden, Andrew D, Lesser, Glenn J, Drappatz, Jan, Ligon, Keith L, Hammond, Samantha N, Lee, Eudocia Q, Reardon, David R, Fadul, Camilo E, Plotkin, Scott R, Batchelor, Tracy T, Zhu, Jay-Jiguang, Beroukhim, Rameen, Muzikansky, Alona, Doherty, Lisa, Lafrankie, Debra, Smith, Katrina, Tafoya, Vida, Lis, Rosina, Stack, Edward C, Rosenfeld, Myrna R, Wen, Patrick Y

Volltext

Association between PIK3CA mutation status and development of brain metastases in HR+/HER2- metastatic breast cancer von Fitzgerald, D.M., Muzikansky, A., Pinto, C., Henderson, L., Walmsley, C., Allen, R., Ferraro, G.B., Isakoff, S., Moy, B., Oh, K., Shih, H.A., Dias-Santagata, D., Iafrate, A.J., Bardia, A., Brastianos, P.K., Juric, D.

Volltext